Join to view full profile
Elm and Carlton StreetsBuffalo, NY 14263
Phone+1 716-845-2300
Dr. George is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saby George is an oncologist in Buffalo, NY and is affiliated with multiple hospitals in the area, including Cleveland Clinic, Miami Valley Hospital, and Roswell Park Comprehensive Cancer Center. He received his medical degree from Kottayam Medical College and has been in practice 18 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in Urologic oncology with a particular research focus on Kidney cancer, prostate cancer, and bladder cancer.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2010
Cleveland Clinic FoundationFellowship, Experimental Therapeutics In Medical Oncology, 2006 - 2008
Wright State UniversityResidency, Internal Medicine, 2003 - 2006
Kottayam Medical CollegeClass of 1999
Certifications & Licensure
NY State Medical License 2010 - 2027
OH State Medical License 2003 - 2027
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Patient Portal and Sunrise Acute Care EHR, Allscripts, 2014
- CMS Meaningful Use Stage 1 Certification Sunrise Patient Portal and Sunrise Ambulatory Care EHR, Allscripts, 2014
- CMS Meaningful Use Stage 1 Certification Sunrise Acute Care Module Set, Allscripts, 2014
Clinical Trials
- Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
- Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2009 Oct 29
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2010 Feb 06
Publications & Presentations
PubMed
- 2 citationsTreatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data.Daniel M Geynisman, Nathan R Hill, Lisa C Rosenblatt, Xin Yin, Valerie B Haley
JCO Oncology Practice. 2025-11-01 - A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot t...Petros Grivas, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun Balar
Future Oncology. 2025-10-01 - 14 citationsSystematic literature review of intravenous versus subcutaneous administration of oncology therapies: A clinical, economic and patient perspective.Saby George, Maria T Bourlon, Michael J Overman, Matt Dixon, Karishma Shelley
Cancer Treatment Reviews. 2025-09-01
Press Mentions
ASCO 2025 Highlights: Menin Inhibitor for Acute Myeloid Leukemia; Organ Transplant and Checkpoint InhibitorsMay 23rd, 2025- Injectable Version of Bristol Myers Squibb Cancer Drug Opdivo Gets USFDA OkayDecember 27th, 2024
- Targeted Combination Shows Promise in Metastatic Kidney CancerNovember 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
